- Wednesday, May 3, 2023
8:00 AM – 8:15 AM ET
Welcome and Introduction
8:00 AM – 8:15 AM ET
Welcome and IntroductionTime Zone: ETCo-Chair: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Co-Chair###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Co-Chair: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### 8:15 AM – 8:50 AM ET
Session 1: Updates in Rare Ovarian Cancers (Low Grade, Non-Serous Epithelial and Non-Epithelial)
8:15 AM – 8:50 AM ET
Session 1: Updates in Rare Ovarian Cancers (Low Grade, Non-Serous Epithelial and Non-Epithelial)Time Zone: ET
Jubilee Brown ### 1862807###Presenter#########Presenter:
### 8:50 AM – 9:00 AM ET
Live Q&A
8:50 AM – 9:00 AM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter:
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Jubilee Brown ### 1862807###Presenter#########Presenter:
### 9:00 AM – 9:15 AM ET
Break
9:00 AM – 9:15 AM ET
Break
Time Zone: ET
9:15 AM – 9:50 AM ET
Session 2: Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial Cancer
9:15 AM – 9:50 AM ET
Session 2: Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial CancerTime Zone: ET
Matthew Powell ### 1929977###Invited Speaker#########Invited Speaker:
### 9:50 AM – 10:00 AM ET
Live Q&A
9:50 AM – 10:00 AM ET
Matthew Powell ### 1929977###Invited Speaker#########Invited Speaker:
### 10:00 AM – 10:15 AM ET
Break
10:00 AM – 10:15 AM ET
Break
Time Zone: ET
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
Time Zone: ET
11:15 AM – 11:30 AM ET
Break
11:15 AM – 11:30 AM ET
Break
Time Zone: ET
11:30 AM – 12:05 PM ET
Session 3: Updates in Recurrent Endometrial Cancer
11:30 AM – 12:05 PM ET
Session 3: Updates in Recurrent Endometrial CancerTime Zone: ETPresenter: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Presenter###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Presenter: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### 12:05 PM – 12:15 PM ET
Live Q&A
12:05 PM – 12:15 PM ET
Live Q&A
Time Zone: ET
12:15 PM – 12:30 PM ET
Break
12:15 PM – 12:30 PM ET
Break
Time Zone: ET
12:30 PM – 1:15 PM ET
Session 4: Assessment and Intervention for Chemotherapy-Induced Neuropathy and Myopathy
12:30 PM – 1:15 PM ET
Session 4: Assessment and Intervention for Chemotherapy-Induced Neuropathy and MyopathyPresenter: – The University of Oklahoma Health Sciences Center/ OU Health Stephenson Cancer Center
Elizabeth Hile, PT, PhD (she/her/hers) – The University of Oklahoma Health Sciences Center/ OU Health Stephenson Cancer Center ### 1862413###Presenter###Associate Professor/ Director of Cancer Rehabilitation Research & Laboratory###The University of Oklahoma Health Sciences Center/ OU Health Stephenson Cancer Center###Presenter: – The University of Oklahoma Health Sciences Center/ OU Health Stephenson Cancer Center
### she/her/hers1:15 PM – 1:30 PM ET
Break
1:15 PM – 1:30 PM ET
Break
Time Zone: ET
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
Time Zone: ET
2:30 PM – 2:45 PM ET
Break
2:30 PM – 2:45 PM ET
Break
Time Zone: ET
2:45 PM – 3:20 PM ET
Session 5: Management of Metastatic/Recurrent Cervical Cancer in the Front Line
2:45 PM – 3:20 PM ET
Session 5: Management of Metastatic/Recurrent Cervical Cancer in the Front LineTime Zone: ET
Krishnansu Tewari ### 1928325###Presenter#########Presenter:
### 3:20 PM – 3:30 PM ET
Live Q&A
3:20 PM – 3:30 PM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Speaker:
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Krishnansu Tewari ### 1928325###Speaker#########Speaker:
### 3:30 PM – 3:45 PM ET
Break
3:30 PM – 3:45 PM ET
Break
Time Zone: ET
3:45 PM – 4:20 PM ET
Session 6: Management of Cervical Cancer
3:45 PM – 4:20 PM ET
Session 6: Management of Cervical Cancer
Time Zone: ET
4:20 PM – 4:30 PM ET
Live Q&A
4:20 PM – 4:30 PM ET
Live Q&A
Time Zone: ET
4:30 PM – 4:45 PM ET
Break
4:30 PM – 4:45 PM ET
Break
Time Zone: ET
4:45 PM – 5:20 PM ET
Session 7: Updates in Molecular Testing and Front-Line Treatment in Ovarian Cancer
4:45 PM – 5:20 PM ET
Session 7: Updates in Molecular Testing and Front-Line Treatment in Ovarian CancerTime Zone: ETPresenter: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
Bradley Monk, MD – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute ### 1186886###Presenter###Gynecologic Oncologist###Director, Principal Investigator, Community Research Development, HonorHealth Research Institute###Presenter: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
### 5:20 PM – 5:30 PM ET
Live Q&A
5:20 PM – 5:30 PM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Bradley Monk, MD – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute ### 1186886###Presenter###Gynecologic Oncologist###Director, Principal Investigator, Community Research Development, HonorHealth Research Institute###Presenter: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
### - Thursday, May 4, 2023
8:00 AM – 8:15 AM ET
Welcome and Introduction
8:00 AM – 8:15 AM ET
Welcome and IntroductionTime Zone: ETCo-Chair: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Co-Chair###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Co-Chair: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### 8:15 AM – 9:00 AM ET
Session 8: Update in Vulvar and Vaginal Cancers
8:15 AM – 9:00 AM ET
Session 8: Update in Vulvar and Vaginal CancersPresenter: – Florida International University
Brian Slomovitz, MD – Florida International University ### 1186890###Presenter###Professor###Florida International University###Presenter: – Florida International University
### 9:00 AM – 9:15 AM ET
Break
9:00 AM – 9:15 AM ET
Break
Time Zone: ET
9:15 AM – 9:50 AM ET
Session 9: Updates in Platinum-Resistant Ovarian Cancer
9:15 AM – 9:50 AM ET
Session 9: Updates in Platinum-Resistant Ovarian Cancer
Time Zone: ET
9:50 AM – 10:00 AM ET
Live Q&A
9:50 AM – 10:00 AM ET
Live Q&A
Time Zone: ET
10:00 AM – 10:15 AM ET
Break
10:00 AM – 10:15 AM ET
Break
Time Zone: ET
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
Time Zone: ET
11:15 AM – 11:30 AM ET
Break
11:15 AM – 11:30 AM ET
Break
Time Zone: ET
11:30 AM – 12:05 PM ET
Session 10: Food Insecurity in Oncology
11:30 AM – 12:05 PM ET
Session 10: Food Insecurity in OncologyTime Zone: ETPresenter: – University of Oklahoma
Christina Washington, MD (she/her/hers) – University of Oklahoma ### 1862808###Presenter###Assistant Professor### University of Oklahoma###Presenter: – University of Oklahoma
### she/her/hers12:05 PM – 12:15 PM ET
Live Q&A
12:05 PM – 12:15 PM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter: – University of Oklahoma
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Christina Washington, MD (she/her/hers) – University of Oklahoma ### 1862808###Presenter###Assistant Professor### University of Oklahoma###Presenter: – University of Oklahoma
### she/her/hers12:15 PM – 12:30 PM ET
Break
12:15 PM – 12:30 PM ET
Break
Time Zone: ET
12:30 PM – 1:05 PM ET
Session 11: Updates from Recent Meetings
12:30 PM – 1:05 PM ET
Session 11: Updates from Recent MeetingsTime Zone: ETPresenter: – University of California, San Diego
Ramez Eskander, MD – University of California, San Diego ### 1416358###Presenter###Associate Professor###University of California, San Diego###Presenter: – University of California, San Diego
### 1:05 PM – 1:15 PM ET
Live Q&A
1:05 PM – 1:15 PM ET
Live Q&ATime Zone: ETPresenter: – University of California, San Diego
Ramez Eskander, MD – University of California, San Diego ### 1416358###Presenter###Associate Professor###University of California, San Diego###Presenter: – University of California, San Diego
### 1:15 PM – 1:30 PM ET
Break
1:15 PM – 1:30 PM ET
Break
Time Zone: ET
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
Time Zone: ET
2:30 PM – 2:45 PM ET
Break
2:30 PM – 2:45 PM ET
Break
Time Zone: ET
2:45 PM – 3:20 PM ET
Session 12: Collateral Damage: Side Effects of Breast Cancer Treatment
2:45 PM – 3:20 PM ET
Session 12: Collateral Damage: Side Effects of Breast Cancer TreatmentTime Zone: ETPresenter: – Texas Oncology -Baylor Charles A. Sammons Cancer Center
Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP – Texas Oncology -Baylor Charles A. Sammons Cancer Center ### 1897031###Presenter###Nurse Practitioner###Texas Oncology -Baylor Charles A. Sammons Cancer Center###Presenter: – Texas Oncology -Baylor Charles A. Sammons Cancer Center
### 3:20 PM – 3:30 PM ET
Live Q&A
3:20 PM – 3:30 PM ET
Live Q&ATime Zone: ETPresenter: – Texas Oncology -Baylor Charles A. Sammons Cancer Center
Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP – Texas Oncology -Baylor Charles A. Sammons Cancer Center ### 1897031###Presenter###Nurse Practitioner###Texas Oncology -Baylor Charles A. Sammons Cancer Center###Presenter: – Texas Oncology -Baylor Charles A. Sammons Cancer Center
### 3:30 PM – 3:45 PM ET
Break
3:30 PM – 3:45 PM ET
Break
Time Zone: ET
3:45 PM – 4:30 PM ET
Session 13: ADCs: A New Technology
3:45 PM – 4:30 PM ET
Session 13: ADCs: A New TechnologyPresenter: – European Insitute of Oncology, IRCCS and University of Milano
Giuseppe Curigliano, Professor MD PhD (he/him/his) – European Insitute of Oncology, IRCCS and University of Milano ### 1867030###Presenter###Clinical Director Early Drug Development Division###European Insitute of Oncology, IRCCS and University of Milano###Presenter: – European Insitute of Oncology, IRCCS and University of Milano
### he/him/his4:30 PM – 4:45 PM ET
Break
4:30 PM – 4:45 PM ET
Break
Time Zone: ET
4:45 PM – 5:20 PM ET
Session 14: Updates in HR-Positive Breast Cancer
4:45 PM – 5:20 PM ET
Session 14: Updates in HR-Positive Breast CancerTime Zone: ETPresenter: – Winship Cancer Institute at Emory University
Kevin Kalinsky, MD, MS (he/him/his) – Winship Cancer Institute at Emory University ### 1538154###Presenter###Director, Glenn Family Breast Center###Winship Cancer Institute at Emory University###Presenter: – Winship Cancer Institute at Emory University
### he/him/his5:20 PM – 5:30 PM ET
Live Q&A
5:20 PM – 5:30 PM ET
Live Q&ATime Zone: ETModerator: – Sarah Cannon Research Institute (SCRI)
Speaker: – Winship Cancer Institute at Emory University
Erika P. Hamilton, MD – Sarah Cannon Research Institute (SCRI) ### 1186741###Moderator###Director, Breast and Gynecologic Cancer Research Program###Sarah Cannon Research Institute (SCRI)###Moderator: – Sarah Cannon Research Institute (SCRI)
### @@@ Kevin Kalinsky, MD, MS (he/him/his) – Winship Cancer Institute at Emory University ### 1538154###Speaker###Director, Glenn Family Breast Center###Winship Cancer Institute at Emory University###Speaker: – Winship Cancer Institute at Emory University
### he/him/his- Friday, May 5, 2023
8:00 AM – 8:15 AM ET
Welcome and Introduction
8:00 AM – 8:15 AM ET
Welcome and Introduction
Time Zone: ET
8:15 AM – 8:50 AM ET
Session 15: Special Topics in HER2 Breast Cancer
8:15 AM – 8:50 AM ET
Session 15: Special Topics in HER2 Breast Cancer
Time Zone: ET
8:50 AM – 9:00 AM ET
Live Q&A
8:50 AM – 9:00 AM ET
Live Q&A
Time Zone: ET
9:00 AM – 9:15 AM ET
Break
9:00 AM – 9:15 AM ET
Break
Time Zone: ET
9:15 AM – 9:50 AM ET
Session 16: Updates in Metastatic Breast Cancer
9:15 AM – 9:50 AM ET
Session 16: Updates in Metastatic Breast Cancer
Time Zone: ET
9:50 AM – 10:00 AM ET
Live Q&A
9:50 AM – 10:00 AM ET
Live Q&A
Time Zone: ET
10:00 AM – 10:15 AM ET
Break
10:00 AM – 10:15 AM ET
Break
Time Zone: ET
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
Time Zone: ET
11:15 AM – 11:30 AM ET
Break
11:15 AM – 11:30 AM ET
Break
Time Zone: ET
11:30 AM – 12:05 PM ET
Session 17: Immunotherapy for Breast Cancer
11:30 AM – 12:05 PM ET
Session 17: Immunotherapy for Breast CancerTime Zone: ETPresenter: – International Breast Cancer Center
Javier Cortes, MD, PhD – International Breast Cancer Center ### 1186877###Presenter###Head###International Breast Cancer Center###Presenter: – International Breast Cancer Center
### 12:05 PM – 12:15 PM ET
Live Q&A
12:05 PM – 12:15 PM ET
Live Q&ATime Zone: ETSpeaker: – International Breast Cancer Center
Javier Cortes, MD, PhD – International Breast Cancer Center ### 1186877###Speaker###Head###International Breast Cancer Center###Speaker: – International Breast Cancer Center
### 12:15 PM – 12:30 PM ET
Break
12:15 PM – 12:30 PM ET
Break
Time Zone: ET
12:30 PM – 1:15 PM ET
Session 18: Care of Special Populations
12:30 PM – 1:15 PM ET
Session 18: Care of Special PopulationsPresenter: – Cedars-Sinai Medical Center
BJ Rimel, MD – Cedars-Sinai Medical Center ### 1538157###Presenter###Associate Professor###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 1:15 PM – 1:30 PM ET
Break
1:15 PM – 1:30 PM ET
Break
Time Zone: ET
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
Time Zone: ET
2:30 PM – 2:45 PM ET
Break
2:30 PM – 2:45 PM ET
Break
Time Zone: ET
2:45 PM – 3:20 PM ET
Session 19: Updates in TNBC
2:45 PM – 3:20 PM ET
Session 19: Updates in TNBC
Time Zone: ET
3:20 PM – 3:30 PM ET
Live Q&A
3:20 PM – 3:30 PM ET
Live Q&A
Time Zone: ET
3:30 PM – 3:45 PM ET
Break
3:30 PM – 3:45 PM ET
Break
Time Zone: ET
3:45 PM – 4:20 PM ET
Session 20: Biosimilars in Breast Cancer Therapy
3:45 PM – 4:20 PM ET
Session 20: Biosimilars in Breast Cancer TherapyTime Zone: ET
William Gradishar ### 1929925###Presenter#########Presenter:
### 4:20 PM – 4:30 PM ET
Live Q&A
4:20 PM – 4:30 PM ET
William Gradishar ### 1929925###Speaker#########Speaker:
### 4:30 PM – 4:45 PM ET
Break
4:30 PM – 4:45 PM ET
Break
Time Zone: ET
4:45 PM – 5:20 PM ET
Session 21: HER2-Low Breast Cancer: Limits of Testing and Where to Go from Here
4:45 PM – 5:20 PM ET
Session 21: HER2-Low Breast Cancer: Limits of Testing and Where to Go from HereTime Zone: ETPresenter: – Dana-Farber Cancer Institute, Harvard Medical School
Paolo Tarantino, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 1928334###Presenter###Advanced Research Fellow###Dana-Farber Cancer Institute, Harvard Medical School###Presenter: – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his5:20 PM – 5:30 PM ET
Live Q&A
5:20 PM – 5:30 PM ET
Live Q&ATime Zone: ETSpeaker: – Dana-Farber Cancer Institute, Harvard Medical School
Paolo Tarantino, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 1928334###Speaker###Advanced Research Fellow###Dana-Farber Cancer Institute, Harvard Medical School###Speaker: – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his
